Cerity Partners’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$603K Buy
23,424
+837
+4% +$19.4K ﹤0.01% 2317
2026
Q1
$465K Sell
22,587
-3,837
-15% -$86.5K ﹤0.01% 2342
2025
Q4
$627K Buy
26,424
+1,514
+6% +$36.9K ﹤0.01% 1966
2025
Q3
$620K Sell
24,910
-1,295
-5% -$27.9K ﹤0.01% 1850
2025
Q2
$603K Buy
26,205
+384
+1% +$8.89K ﹤0.01% 1769
2025
Q1
$580K Buy
25,821
+14,195
+122% +$330K ﹤0.01% 1679
2024
Q4
$213K Sell
11,626
-2,095
-15% -$41.5K ﹤0.01% 2211
2024
Q3
$250K Buy
+13,721
New +$262K ﹤0.01% 2188
2024
Q2
Sell
-15,229
Closed -$298K 2375
2024
Q1
$298K Buy
+15,229
New +$322K ﹤0.01% 1871

Other funds holding PRVA

Cerity Partners's PRVA Position: Q2 2026 in Review

Cerity Partners increased its Privia Health (PRVA) stake by 3.7% in Q2 2026, buying an estimated $19.4K and bringing the position to 23,424 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

Cerity Partners first reported a position in PRVA in Q1 2024 and has held it in 9 quarters since. The position peaked at $627K in Q4 2025. 281 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Cerity Partners held 23,424 shares of Privia Health worth $603K as of Q2 2026.
  • Cerity Partners bought 837 Privia Health shares in Q2 2026, an estimated $19.4K.
  • Privia Health made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2317 holding.
  • Cerity Partners first reported a position in Privia Health in Q1 2024 and has held it in 9 quarters since.
  • Cerity Partners's Privia Health position peaked at $627K in Q4 2025.
  • 281 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.